Skip to content

Yogic Breathing and IBS

Effects of Yogic Breathing on Microvascular Endothelial Function and Symptoms in Participants With IBS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04225104
Enrollment
14
Registered
2020-01-13
Start date
2019-04-15
Completion date
2020-03-01
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBS - Irritable Bowel Syndrome

Brief summary

Adults with irritable bowel syndrome (IBS) are being randomized to a yogic breathing or control condition. Participants randomized to the yogic breathing group will be asked to complete a 2-minute yogic breathing video 5 to 7 days per week at home for 4 weeks and control group participants will be asked to maintain their current activities. Participants in this group will be given access to the yogic breathing video at the end of the 4-week control period. IBS symptoms and autonomic and vascular function will be assessed at baseline and at the end of week 4 in both groups.

Interventions

BEHAVIORALYogic breathing intervention

Yogic breathing will be completed while following a video provided by the investigative team. Breathing practices consist of slow, deep, relaxation breathing and are led by a certified yoga instructor.

Sponsors

Texas State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Members of the investigative team will be blinded to the participant's group assignment until all testing is completed.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Must have a formal diagnosis of IBS and not be enrolled in any other clinical trials.

Exclusion criteria

* 1\) current, regular practice of yogic breathing at least 5 minutes per day and 2) chronic obstructive pulmonary disease

Design outcomes

Primary

MeasureTime frameDescription
IBS SymptomsOnce at baselineIBS-Symptom Severity Scale will be administered.
Autonomic functionOnce at baselineHeart rate variability will be assessed.
Microvascular functionOnce at baselineLaser Doppler flowmetry at baseline and in response to local heating will be measured.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026